September 21st, 2018

 

 

Dr. Malik Sahily

"TBD"

Location: Leventhal Conference Room


September 14th, 2018

 

 

Dr. Lori Maxfield

Biosafety Training

Location: Sherman Auditorium


September 7th, 2018

 


August 31st, 2018

 

 

Dr. Galit Alter
“TBD"

Location: Leventhal Conference Room


August 24th, 2018

 

 

Dr. Christa Osuna
“TBD"

Location: Leventhal Conference Room


August 17th, 2018

 

 

Dr. Katy Stepheson
“HPX1002/IPCAVD010: A Randomized Controlled Trial of Shorter and Simpler Vaccine Schedules using Ad26.Mos.HIV + gp140 ENV Protein”

Location: Leventhal Conference Room


August 10th, 2018

 

 

Dr. Michael Seaman
"Combinations of Broadly Neautralizing Antibodies for Passive Infusion Clinical Trials"

Location: Leventhal Conference Room


August 3rd, 2018

 

 

Dr. Rebecca Zach
““The Safety of Antiretroviral Treatment in Pregnancy"

Location: Leventhal Conference Room


Dr. Linette Lin Lu
“Dissecting Antibody Functions in Tuberculosis"

Location: Leventhal Conference Room

July 27th, 2018


July 20th, 2018

Dr. Olivier Lucar
"Cloning of Natural Killers Cells: Exploration of Their Memory"

Location: Leventhal Conference Room


Dr. Lisa Tostanoski
"“Engineering Immune Responses with Biomaterials”

Dr. Susan Park Ochsner
"“Vaccination Strategies with Novel HIV-1 Trimeric Envelope Proteins”

Location: Leventhal Conference Room

July 13th, 2018


July 6th, 2018

Dr. Bryan Bryson
"Harnessing innate immunity in Mycobacterium tuberculosis infection"

Location: Leventhal Conference Room


July 29th, 2018

Dr. George Church
"Engineering (1) Cells Resistant To All Viruses, (2) Viral Tropism & Immunity"

Location: Leventhal Conference Room


June 22nd, 2018

Anthony Cadena

“The Elusive Reservoir Under HAART – Uncovering and Eliminating HIV Latency”

Location: Leventhal Conference Room


June 15th, 2018 

Dr. Jeff Wagner
"Live and Let Die: Development of a Mycobacterium Tuberculosis Human Challenge Strain"

Location: Leventhal Conference Room


June 8th, 2018 

Justin Iampietro
"Immunogenicity and Cross-activity of Rhesus Adenoviral Vectors"

Location: Kirstein Living Room


June 1st, 2018

Dr. Vaishali Moulton
"Serine Arginine Rich Splicing Factor 1(SRSF1): New Kid on the "Immunity/Autoimmunity" Block"

Location: Leventhal Conference Room


May 25th, 2018

Dr. Georg Gerber
"The Dynamic Microbiome"

Location: Leventhal Conference Room


May 18th, 2018 

Christopher R. Brennan, MPH
"Getting To Zero In Massachusetts: The Vision, The Reality, The Future"

Location: Leventhal Conference Room


May 11th, 2018

Dr. Zach Herbert - Dana Farber Cancer Institute
"RNAseq: Choosing between too many choices”

  Location: Leventhal Conference Room


May 4th, 2018

Eryn Blass - Center for Virology and Vaccine Research
"Adenovirus Vector Vaccination Impacts NK Rheostat Function Following LCMV Infection” 

Zi Han Kang -Center for Virology and Vaccine Research
"Similar epitope specificities of IgG and IgA antibodies elicited by Ad26 vector prime, Env protein boost immunizations in rhesus monkeys”


Dr. Xuan He - Center for Virology and Vaccine Research
“Innate and Adaptive Immune Activation following Mucosal SIV Infection of Rhesus Macaques”

April 27th, 2018


April 20th, 2018

Dr. Melinda Hanes
"Cosmc and the Biosynthesis of Core 1 O-glycans – from Homeostasis, Pathology, to Therapeutics”


April 13th, 2018

Dr. Xuan He- Center for Virology and Vaccine Research
“Innate and Adaptive Immune Activation following Mucosal SIV Infection of Rhesus Macaques”


April 6th, 2018 

Dr. Lawrence Tartaglia - Center for Virology and Vaccine Research
"Alpha Defensins in Adenovirus Infection: Friends or Foes?”

Dr. Cordelia Manickam - Center for Virology and Vaccine Research
“Characterization of Novel Natural Killer – Like B Cells in Humans and NHP”


March 30th, 2018

Dr. Rafael Larocca
"Zika virus vaccine development. What have we learned?”


March 23rd, 2018 

Dr. Christian Forst
"Integrative network analysis identifies key signatures, intrinsic networks and host factors for influenza and Zika virus    infections”


March 16th, 2018

Dr Daniel R. Kuritzkes - Brigham and Women's Hospital
"“Clinical trials of HIV cure: What have we learned?”


March 9th, 2018

Professor Gary King - Harvard Univeristy
"Matching Methods for Causal Inference”


March 2nd, 2018

Dr. Nicolas Huot - Institut Pasteur
"CXCR5+ NK cells : when, where and how do they kill?”


February 23rd, 2018

Dr. Stephanie Jost - Center for Virology and Vaccine Research
"Expression and Function of Semaphorin 7A in Natural Killer Cells


February 16th, 2018

Dr. Amy Barczak - Ragon Institute
"Seeing" TB: Investigating How PAMP/PRR Interactions Shape the Macrophage Response to Mycobacterium Tuberculosis


Dr. Richard Cummings - Beth Israel Medical Center
"“Glycan Receptors for Respiratory Viruses”

February 2nd, 2018



Dr. Diane Mathis - Harvard Medical School
"Tissue-Treg Control of Non-immunological Processes”

January 19th, 2018


January 12th, 2018

Dr. James Mitchell - Department of Genetics and Complex Diseases
“Host diet-pathogen interaction: the role of adipose tissue in cerebral malaria pathogenesis"


January 5th, 2018

Dr. Nir Hacohen - MGH Center for Center Immunotherapy
“Learning and Applying the Rules of Tumor Immunity in Humans”


December 15th, 2017

Dr. Siddhant Gupte - Center for Virology and Vaccine Research

“Development of Improved SIMIAN/HUMAN Immunodeficiency Viruses From HIV-1 Clades AE, B AND C”


December 1st, 2017

Dr. Saul Tzipori - Tufts University

“The reemergence of cryptosporidiosis as a significant disease of children, and the renewed search for treatment and prevention”


Dr. Amy Barczak - Ragon Institute

"Seeing" TB: Investigating How PAMP/PRR Interactions Shape the Macrophage Response to Mycobacterium Tuberculosis

November 17th, 2017


Dr. Daniel Ram & Dr. Malika Aid - Center for Virology and Vaccine Research
Tracking the Evolution of NK Cell Responses to SIV and CMW Infection in Rhesus Macaques

November 10th, 2017


Dr. Paul Blainey - Broad Institute of MIT and Harvard
A New Platform Technology for Micro-Scale Biological Assays and Drug Discovery

November 4th, 2017


Dr. Phyllis Kanki - Department of Immunology and Infectious Disease at Harvard School of Public Health
West African Pathogen:  HIV-2 and Zika Virus

October 27th, 2017


Peter Healy - President of Beth Israel Deaconess Medical Center
Achieving Our Mission:  Extraordinary Care, Supported by World Class Education and Research

October 20th, 2017


Dr. Vasudevan Achuthan - Department of Cancer Immunology and Virology at the Dana Farber Cancer Institute
Virus-Host Interactions Regulating HIV-1 Nuclear Distribution and Latency

October 13th, 2017


Dr. Amanda Martinot - Center for Virology and Vaccine Research
Zikavirus and Pregnancy - a Non-Human Primate Model

October 6th, 2017


Dr. Kevin Esvelt - Sculpting Evolution Group at MIT Media Lab
Heritably Immunizing the Reservoirs of Tick-borne Disease

September 29th, 2017


Dr. John Coffin - Sackler School of Graduate Biomedical Sciences at Tufts University
HIV Provirus Integration and Expression on Long-Term Suppressive Therapy

September 22nd, 2017


Dr. James Whitney - Center for Virology and Vaccine Research
NHP Models of Zika

September 15th, 2017


Dr. Jinyan Liu - Center for Virology and Vaccine Research
Isolation of Zika PIV Vaccine Induced Specific Antibodies

August 18th, 2017


Dr. Christine Bricault - Center for Virology and Vaccine Research
Longitudinal, Sequential Vaccination with HIV-1 Env gp140 Elicits Durable, Tier 2 Neutralizing Antibody Responses to Variable Loop 3

Dr. Christy Lavine - Seaman Laboratory at the Center for Virology and Vaccine Research
Development of ART-Resistant HIV-1 Pseudoviruses for the Detection of Neutralizing Antibodies In Patients on Drug Therapy

August 11th, 2017


Dr. Katy Stephenson - Center for Virology and Vaccine Research
Clinical Development of Zika Virus Purified Inactivated Vaccine: Update and Preliminary Findings

August 4th, 2017


Dr. Sabrina Tan - Center for Virology and Vaccine Research
HIV in the Brain

July 28th, 2017


Dr. Jonathan Abraham - Brigham and Women's Hospital
Molecular Mechanism for Antibody-Mediated Cross-Neutralization of Divergent Hemorrhagic Fever Arenaviruses

July 21st, 2017


Dr. So-Yon-Lim - Center for Virology and Vaccine Research
Genetic Variation of Human TRIM6 Gene and its Implication in in vitro Susceptibility to HIV-1 Infection

July 14th, 2017


Dr. Rafael Larocca - Center for Virology and Vaccine Research
Zika Virus Persistence in CNS and Lymph Nodes of Rhesus Monkeys

July 7th, 2017


Zi Han Kang - Center for Virology and Vaccine Research
Induction of Antibody Responses by HIV-1 Env

Dr. Xuan He - Center for Virology and Vaccine Research
Targeting Different Epitopes on the HIV-1 Envelope with an Engineered Bispecific Antibody

June 30th, 2017


Po-Ting Liu - Center for Virology and Vaccine Research
Protection Against a Mixed SHIV Challenge by a Broadly Neutralizing Antibody Cocktail

June 23rd, 2017


Dr. Malika Aid - Center for Virology and Vaccine Research
Meta-Analysis of HIV Integration Sites

June 16th, 2017


Dr. Philip J. Kranzusch - Kranzusch Lab at Dana-Farber Cancer Institute
Ancient cGAS-STING pathways reveal evolution of human innate immunity

June 9th, 2017


Dr. Douglas Kwon - Ragon Institute of MGH, MIT, and Harvard
The cervicovaginal microbiome, genital inflammation, and HIV risk

June 2nd, 2017


Dr. Manolis Kellis - MIT Computer Science and Artificial Intelligence Lab
From genomics to therapeutics: Uncovering and manipulating the circuitry of non-coding disease variants and cancer

May 19th, 2017


Justin Iampietro - Center for Virology and Vaccine Research
Evaluation of Immune Responses to Rhesus Adenoviruses

May 12th, 2017


Dr. Sampa Santra - Center for Virology and Vaccine Research
Protective efficacies of RV144-derived neutralizing and non-neutralizing monoclonal antibodies in antibody-mediated mucosal SHIV challenges in rhesus monkeys

May 5th, 2017


Joseph Nkolola, PhD - Center for Virology and Vaccine Research
HIV Envelope Trimer Immunization in Non-Human Primates to Elicit Tier 2 Neutralizing Antibodies

Eryn Blass - Center for Virology and Vaccine Research
The role of Natural Killer Cells in the Vaccine Setting

April 28th, 2017


Dr. Amanda Martinot - Center for Virology and Vaccine Research
Loss of Mtb Lipoprotein LprG Leads to Unique Lipid Signature and Enhanced Cellular Immune Responses to TB Antigens

April 21st, 2017


Dr. Alexander Badamchi-Zadeh - Center for the Virology and Vaccine Research
Vectored PGT121 Gene Delivery Approached Against HIV-1 Infection

April 14th, 2017


Spandan Shah - Reeves Laboratory at the Center for Virology and Vaccine Research
FcgR∆g Memory-Like NK Cells in Human and Rhesus

April 7th, 2017


Dr. Florian Winau - Children's Hospital Boston and Harvard Medical School
Lipid Scramblase - A New Target in Chronic Viral Infection

March 24th, 2017


Kathryn Stephenson, M.D. - Center for Virology and Vaccine Research
Clinical Development of Zika Virus Purified Inactivated Vaccine

March 17th, 2017


Dr. Simon Robson - Liver, Transplantation and Vascular Biology Centers at Beth Israel Deaconess Medical Center
CD39 and Purinergic Signaling:  Conditioning of Immune Responses

March 10th, 2017


Lawrence Tartaglia, PhD - Center for Virology and Vaccine Research
Insight Into Alpha Defensin-adenovirus Interactions

Peter Abbink - Center for Virology and Vaccine Research
Development and Characterization of Novel RhAd Vaccine Vectors

March 3rd, 2017


Dr. Rick Malley - Senior Physician in Medicine and Professor of Pediatrics at the Division of Infectious Diseases at Boston Children’s Hospital
Creating Vaccines for the Developing World:  A Tale of Affinities

February 24th, 2017


Kevin Pastores - Center for Virology and Vaccine Research
Development of Novel SHIVs from HIV-1 Clades

Kittipos Visitsunthorn - Center for Virology and Vaccine Research
Longitudinal Evaluation of anti-ZIKV Antibody Response Following Vaccination

February 17th, 2017


Dr. Nir Eyal - Harvard RH Chan School of Public Health
How to Keep Risky HIV Cure-Related Trials Ethical

February 10th, 2017


Dr. Stephanie Jost - Center for Virology and Vaccine Research
Virus Specific Responses Mediated by Human Natural Killer Cells

February 3rd, 2017


Dr. Amanda Martinot - Center for Virology and Vaccine Research
Loss of Mycobacterium Tuberculosis Lipoprotein LprG Leads to Unique Lipid Signature and Enhanced Cellular Immune Response to TB Antigens

January 20th, 2017


Stephen Walsh, M.D. - Principle Investigator of Walsh Laboratory and Assistant Professor of Medicine at Harvard Medical School
Monoclonal Antibodies to Prevent HIV-1 Infection

December 16th, 2016


Chris Sassetti, PhD - Associate Professor at University of Massachusetts Medical School Department of Microbiology and Physiological Systems
Genetic Dissection of Protective Immunity to Tuberculosis

December 2nd, 2016


Arup K. Chakraborty, PhD - MIT's Laboratory for Computational Immunology
How To Hit HIV Where It Hurts

November 18th, 2016


Jinyan Liu, MD, PhD - Center for Virology and Vaccine Research
HIV Vaccine Pre-Clinical Test in Rhesus Macaque

November 11th, 2016


Christy L. Lavine, PhD - Center for Virology and Vaccine Research
Development of ART-Resistant HIV-1 Pseudoviruses for the Detection of Neutralizing Antibodies in Patient on Drug Therapy

Christine Bricault, PhD - Center for Virology and Vaccine Research
Longitudinal Vaccination of Guinea Pigs with HIV-1 Env gp140 Immunogens

October 28th, 2016


Sarah Fortune, MD - Harvard TH Chan School of Public Health & Principle Investigator of the Fotune Lab/Director of TB Research Program at the Ragon Institute
Identifying and Targeting Innate Determinants of TB Clearance

October 21st, 2016


Alex Badamchi-Zadeh, MA, MRes, PhD - Center for Virology and Vaccine Research
Vaccination and Epigenetic Inhibition Towards Cancer Immunotherapy

Po-Ting Liu, MS - Center for Virology and Vaccine Research
A Journey From Nucleus into Cytoplasm - The Epstein-Barr Virus

October 14th, 2016


Ildiko Van Rhijn, PhD - Brigham and Women's Hospital & Harvard Medical School, Assistant Professor
Antigen Specificity and T Cell Receptor Conservation in the Human CD1 System

October 7th, 2016


Joseph Nkoloa, PhD - Center for Virology and Vaccine Research
Evaluation of HIV-1 Monoclonal Antibody PGT121 Anti-Idiotype Platforms

Cordelia Manickam, PhD - Center for Virology and Vaccine Research
Acute Liver Damage Associated with Innate Immune Activation in Small Nonhuman Primate Model of Hepacivirus Infection

September 30th, 2016


Jonathan Kagan, PhD - Kagan Labs, Boston Children's Hospital & Associate Professor, Harvard Medical Center
Initiation and Regulation of Innate Immunity

September 23rd, 2016


Daniel Ram, PhD - Center for Virology and Vaccine Research
Balance Between Short and Long Isoforms of cFLIP Regulates Fas-Mediated Apoptosis In Vivo

September 16th, 2016


Nichole Klatt, PhD - Department of Pharmaceutics at the University of Washington
Microbial Interactions in HIV Transmission and Pathogenesis

September 9th, 2016


Malika Aid PhD - Center for Virology and Vaccine Research
FOXO3A, IRF-3 and IRF-7 Regulate Protective-Vaccine Induced Immunity

Amanda Martinot, DVM MPH PhD - Center for Virology and Vaccine Research
Immunotherapy for Mycobacterium Tuberculosis Infection

August 26th, 2016


Dr. Gabriel Victoria
Clonal Dynamics of Antibody Evolution in Germinal Centers

August 12th, 2016


Lawrence Tartaglia, PhD - Center for Virology and Vaccine Research
Alpha Defensins in Adenovirus Infection:  Friend or Foe?

Christa Osuna, MPH PhD - Center for Virology and Vaccine Research
TCR Affinity Associated with Functional Differences Between Dominant and Subdominant SIV Epitope-Specific CD8+ T Cells in Mamu-A*01 + Rhesus Monkeys

August 5th, 2016


Dr. Samuel Behar - University of Massachusetts Medical School
T Cells, Protective Immunity, and Vaccines Against Tuberculosis

July 29th, 2016


Sabrina Tan, M.D. - Harvard Medical School & Beth Israel Deaconess Medical Center, Center for Virology and Vaccine Research
Immune Senescence Predicts BK Virus Reactivation After Kidney Transplant

July 22nd, 2016


James Whitney, PhD - Ragon Institute of MGH, MIT, and Harvard & Center for Virology and Vaccine Research
Development of TLR Agonists as HIV Eradication Therapeutics

July 8th, 2016


Christian Wuthrich, PhD - Division of Neuro-Immunology & Center for Virology and Vaccine Research
Staining & Image Analyses of the Wood and Bark of the European Beech & Immune Response Against JC Virus Infection of Human Neruons

June 24th, 2016


Dr. Facundo Batista - Ragon Institute of MGH, MIT and Harvard
Early Production of IL-4 by Macrophage-Primed NKTs Supports B Cell Immunity to Infection

June 17th, 2016


Dr. Rafael Larocca & Peter Abbink - Center for Virology and Vaccine Research
Development of Zika Virus Vaccines

June 10th, 2016


Zi Han Kang - Center for Virology and Vaccine Research
Induction of Antibody Responses with HIV-1 Env

June 3rd, 2016


Dr. Lori Maxfield - Center for Virology and Vaccine Research
Adenovirus Recombination in vivo

May 27th, 2016


Bruce Walker, M.D. - Ragon Institute of MGH, MIT and Harvard and Harvard University Center for AIDS Research
Hyper Acute HIV Infection

May 20th, 2016


Justin Iampietro - Center for Virology and Vaccine Research
Evaluation of Immune Responses to Novel Rhesus Adenoviruses

May 13th, 2016


Eryn Blass - Center for Virology and Vaccine Research
The Role of Natural Killer Cells in the Vaccine Setting

April 29th, 2016


Andrew D. Luster, M.D., PhD - Center for Immunology and Inflammatory Diseases & Massachusetts General Hospital
Humanized BLT Mice to Study HIV Transmission

April 22nd, 2016


Dr. Alexander Badamchi-Zadeh - Center for Virology and Vaccine Research
Combining HDAC and BET Inhibitors Enhances Adenoviral-Vector Elicited Secondary Immune Responses, Yet Alters Elicited Antibody Isotype

Dr. So-Yun Lim - Center for Virology and Vaccine Research
Evaluation of a bioinformatically optimized  Mosaic M SOSIP gp140 HIV-1 Envelope Trimer

April 15th, 2016


Terry B. Strom, M.D. - Professor of Medicine & Surgery, Harvard Medical School - Director of Immunology, Beth Israel Deaconess Medical Center
Catalyzing Tolerance with Cell Based Treatment

April 8th, 2016


Joseph Nkolola, PhD - Center for Virology and Vaccine Research
Evaluation of Bioinformatically Optimized Mosaic M SOSIP gp140 HIV-1 Envelope Trimer

Dr. Xin Dang - Center for Virology and Vaccine Research
IncuCyte ZOOM, the Live Cell Imaging System in iLOV Study

April 1st, 2016


Stephanie Jost, PhD - The Ragon Institute of MGH, MIT, and Harvard
Natural Killer Cell Responses in HCV, Influenza, and HIV Infections

March 18th, 2016


Galit Alter, PhD - The Ragon Institute of MGH, MIT, and Harvard
Defining Novel Correlates of Humoral Immune Protection Against Infection

March 11th, 2016


Kathryn Stephenson, M.D., M.P.H - Center for Virology and Vaccine Research
Early Phase and First-in-Human Clinical Research at CVVR

March 4th, 2016


Lawrence Tartaglia & Petter Abbink - Center for Virology and Vaccine Research
Generation and Evaluation of Novel Adeno-Associated Viruses for HIV-1 Broadly Neutralizing Antibody Delivery

February 19th, 2016


Christine Bricault - Center for Virology and Vaccine Research
Rational Design of HIV-1 Envelope Immunogens and the Elicitation Neutralizing Antibodies in the Guinea Pig Model

February 12th, 2016


Stephen Walsh, M.D.
Orthopoxcirus-Vectored Vaccines

February 5th, 2016


January 29th, 2016

Vijay K. Kuchroo DVM, PhD - Director of the Evergrande Center for Immunologic Diseases
Identification of Novel Inhibitory Receptors


Francisco J. Quintana, PhD. - The Ann Romney Center for Neurologic Diseases
Regulation of CNS Inflammation

January 15th, 2016


Christian Wuthrich - University of Geneva
JC Virus Infects Neurons and Glial Cells in the Hippocampus of Patients with JCV CNS Infection

Quazim Alayo - Harvard Medical School Graduate Student
Dissecting the Mechanisms of Ad5-Induced Immune Dysfunctions

January 8th, 2016